The Complex Anatomy of Drug R&D
Science Business: The Promise, the Reality, and the Future of Biotech
- チャプター
In order to appreciate the revolutionary changes taking place in the drug sciences, as well as understand the fundamental management and economic challenges of companies in the drug business, we need to understand the drug R&D process and its unique characteristics. These characteristics create unique business challenges and explain why strategies and approaches can not be borrowed wholesale from other contexts. This chapter is excerpted from "Science Business: The Promise, the Reality, and the Future of Biotech."
- 出版日
- 2006/11
- 領域
- 経営・戦略
- ボリューム
- 15ページ
- コンテンツID
- CCJB-HBS-6605BC
- オリジナルID
- 6605BC
- ケースの種類
- Press Chapter
- 言語
- 英語
- カラー
- 製本の場合、モノクロ印刷での納品となります。
関連ケース
-
The Science-Based Business: A Novel Experiment
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 1,969
¥ 1,353
-
Mapping the Scientific Landscape: Advances in the Drug Sciences
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 2,046
¥ 1,353
-
Drug R&D and the Organizational Challenges
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 2,046
¥ 1,353
-
The Anatomy of a Science-Based Business
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 2,189
¥ 1,463
-
The Performance of the Biotech Industry: Promise Versus Reality
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 1,969
¥ 1,353
-
The Monetization of Intellectual Property: The Forces that Drive the Business of Biotechnology
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 2,123
¥ 1,463
-
Organizational Strategies and Business Models: Better Biotechnology
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 2,046
¥ 1,353
-
The Path Ahead: Toward Science-Based Enterprise
Science Business: The Promise, the Reality, and the Future of Biotech
¥ 1,969
¥ 1,353